JCI - Citations to Entry of parainfluenza virus into cells as a target for interrupting childhood respiratory disease

Citations to this article

Entry of parainfluenza virus into cells as a target for interrupting childhood respiratory disease

Published July 1, 2005
Citation Information: J Clin Invest. 2005;115(7):1688-1698. https://doi.org/10.1172/JCI25669.

View: Text | PDF

Science in Medicine

Total citations by year

Year:	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	Total
Citations:	1	7	1	4	7	8	7	9	5	5	4	8	10	7	9	4	8	3	5	3	1	116

Citation information

Citations to this article (116)

Title and authors	Publication	Year
Potential Broad-Spectrum Antiviral Agents: A Key Arsenal Against Newly Emerging and Reemerging Respiratory RNA Viruses Luong QX, Hoang PT, Ho PT, Ayun RQ, Lee TK, Lee S	International Journal of Molecular Sciences	2025
Universal paramyxovirus vaccine design by stabilizing regions involved in structural transformation of the fusion protein Langedijk JP, Cox F, Johnson NV, van Overveld D, Le L, van den Hoogen W, Voorzaat R, Zahn R, van der Fits L, Juraszek J, McLellan JS, Bakkers MJ	Nature Communications	2024
Paramyxovirus matrix proteins modulate host cell translation via exon-junction complex interactions in the cytoplasm Hung CT, Haas GD, Watkinson RE, Chiu HP, Kowdle S, Stevens CS, Park A, Wohlschlegel JA, Thibault PA, Lee B	bioRxiv	2024
Drug repurposing to tackle parainfluenza 3 based on multi-similarities and network proximity analysis Chen X, Zhou B, Jiang X, Zhong H, You A, Zou T, Zhou C, Liu X, Zhang Y	Frontiers in Pharmacology	2024
Human parainfluenza virus 3 field strains undergo extracellular fusion protein cleavage to activate entry Stearns K, Lampe G, Hanan R, Marcink T, Niewiesk S, Sternberg SH, Greninger AL, Porotto M, Moscona A	mBio	2024
Development of Primer Panels for Amplicon Sequencing of Human Parainfluenza Viruses Type 1 and 2 Mansour O, Fadeev AV, Perederiy AA, Danilenko DM, Lioznov DA, Komissarov AB	International Journal of Molecular Sciences	2024
Epidemiological, Clinical, and Genomic Traits of PIV in Hospitalized Children After the COVID‐19 Pandemic in Wuhan, China Huang J, Li Y, Chen H, Liu H, Li W, Isiaka ID, Du H, Noman M, Rizwan MA, Du Q, Li Y, Lin Y, Liu Y, Lu X, Liu D, Yan Y	Journal of Medical Virology	2024
The structural basis of protective and nonprotective human monoclonal antibodies targeting the parainfluenza virus type 3 hemagglutinin-neuraminidase Miller RJ, Durie IA, Gingerich AD, Elbehairy MA, Branch AG, Davis RG, Abbadi N, Brindley MA, Mousa JJ	Nature Communications	2024
Paramyxoviruses: Pathogenesis, Vaccines, Antivirals, and Prototypes for Pandemic Preparedness Duprex WP, Dutch RE	The Journal of Infectious Diseases	2023
Modeling Infection and Tropism of Human Parainfluenza Virus Type 3 in Ferrets L Rijsbergen, K Schmitz, L Begeman, J Drew-Bear, L Gommers, M Lamers, A Greninger, B Haagmans, M Porotto, R de Swart, A Moscona, R de Vries, C Coyne	mBio	2022
The Importance of Lipid Conjugation on Anti-Fusion Peptides against Nipah Virus Marques MC, Lousa D, Silva PM, Faustino AF, Soares CM, Santos NC	Biomedicines	2022
Epicatechin analogues may hinder human parainfluenza virus infection by inhibition of hemagglutinin neuraminidase protein and prevention of cellular entry. Bhasin S, Nadar M, Hasija Y	Journal of Molecular Modeling	2022
Biological Significance of Dual Mutations A494D and E495K of the Genotype III Newcastle Disease Virus Hemagglutinin-Neuraminidase In Vitro and In Vivo. Lu X, Zhan T, Liu K, Chen Y, Hu Z, Hu J, Gu M, Hu S, Wang X, Liu X, Liu X	Viruses	2022
Human parainfluenza virus evolution during lung infection of immunocompromised humans promotes viral persistence Alexander L. Greninger, Ksenia Rybkina, Michelle J. Lin, Jennifer Drew-Bear, Tara Marcink, Ryan C Shean, Negar Makhsous, Michael Boeckh, Olivia Harder, Francesca Bovier, Shana R Burstein, Stefan Niewiesk, Bert Rima, Matteo Porotto, Anne Moscona	Journal of Clinical Investigation	2021
Virus-Induced Changes of the Respiratory Tract Environment Promote Secondary Infections With Streptococcus pneumoniae V Sender, K Hentrich, B Henriques-Normark	Frontiers in Cellular and Infection Microbiology	2021
Interplay between hypoxia and inflammation contributes to the progression and severity of respiratory viral diseases S Bhattacharya, S Agarwal, NM Shrimali, P Guchhait	Molecular Aspects of Medicine	2021
Roles of conserved residues in the receptor binding sites of human parainfluenza virus type 3 HN protein F Chu, H Wen, G Hou, B Lin, W Zhang, Y Song, G Ren, C Sun, Z Li, Z Wang	Microbial Pathogenesis	2021
Potential treatment of COVID-19 with traditional chinese medicine: What herbs can help win the battle with SARS-CoV-2? L Li, Y Wu, J Wang, H Yan, J Lu, Y Wan, B Zhang, J Zhang, J Yang, X Wang, M Zhang, Y Li, L Miao, H Zhang	Engineering	2021
Exploring the potential of foodborne transmission of respiratory viruses B O'Brien, L Goodridge, J Ronholm, N Nasheri	Food Microbiology	2021
Parainfluenza virus entry at the onset of infection. Marcink TC, Porotto M, Moscona A	Advances in virus research	2021
Molecular evolution of the hemagglutinin-neuraminidase (HN) gene in human respirovirus 3 J Aso, H Kimura, H Ishii, T Saraya, D Kurai, K Nagasawa, Y Matsushima, A Ryo, H Takizawa	Virus Research	2020
Identification of the Functional Domain of HPIV3 Matrix Protein Interacting with Nucleocapsid Protein X Deng, C Zhang, K Zhang, N Lu, Y He, J Liu, Z Yang, G Zhang, M Fiore	BioMed Research International	2020
Human parainfluenza virus fusion complex glycoproteins imaged in action on authentic viral surfaces TC Marcink, T Wang, A des Georges, M Porotto, A Moscona, FA Rey	PLoS pathogens	2020
Orally efficacious broad-spectrum allosteric inhibitor of paramyxovirus polymerase RM Cox, J Sourimant, M Toots, JJ Yoon, S Ikegame, M Govindarajan, RE Watkinson, P Thibault, N Makhsous, MJ Lin, JR Marengo, Z Sticher, AA Kolykhalov, MG Natchus, AL Greninger, B Lee, RK Plemper	Nature Microbiology	2020
Sumoylation of Human Parainfluenza Virus Type 3 Phosphoprotein Correlates with A Reduction in Viral Replication Q Cheng, W Huai, X Wu, M Chen	Virologica Sinica	2020
Molecular Evolution of the Fusion Protein (F) Gene in Human Respirovirus 3 J Aso, H Kimura, H Ishii, T Saraya, D Kurai, Y Matsushima, K Nagasawa, A Ryo, H Takizawa	Frontiers in microbiology	2020
Hijacking the Fusion Complex of Human Parainfluenza Virus as an Antiviral Strategy TC Marcink, E Yariv, K Rybkina, V Más, FT Bovier, A des Georges, AL Greninger, CA Alabi, M Porotto, N Ben-Tal, A Moscona, WA Hendrickson	mBio	2020
A broad-spectrum virus- and host-targeting peptide against respiratory viruses including influenza virus and SARS-CoV-2 H Zhao, KK To, KH Sze, TT Yung, M Bian, H Lam, ML Yeung, C Li, H Chu, KY Yuen	Nature Communications	2020
Involvement of Actin-Regulating Factor Cofilin in the Inclusion Body Formation and RNA Synthesis of Human Parainfluenza Virus Type 3 via Interaction With the Nucleoprotein Y Li, C Zhang, N Lu, X Deng, G Zang, S Zhang, H Tang, G Zhang	Frontiers in microbiology	2019
Inhibiting Human Parainfluenza Virus Infection by Preactivating the Cell Entry Mechanism SF Bottom-Tanzer, K Rybkina, JN Bell, CA Alabi, C Mathieu, M Lu, S Biswas, M Vasquez, M Porotto, JA Melero, V Más, A Moscona, S Schultz-Cherry	mBio	2019
New antiviral approaches for human parainfluenza: Inhibiting the haemagglutinin-neuraminidase VP Chibanga, L Dirr, P Guillon, IM El-Deeb, B Bailly, RJ Thomson, M von Itzstein	Antiviral Research	2019
PI4KB on Inclusion Bodies Formed by ER Membrane Remodeling Facilitates Replication of Human Parainfluenza Virus Type 3 Z Li, D Guo, Y Qin, M Chen	Cell Reports	2019
Lectin antagonists in infection, immunity, and inflammation J Meiers, E Siebs, E Zahorska, A Titz	Current Opinion in Chemical Biology	2019
Cholesterol 25-Hydroxylase inhibits bovine parainfluenza virus type 3 replication through enzyme activity-dependent and -independent ways L Lv, G Zhao, H Wang, H He	Veterinary Microbiology	2019
Molecular docking analysis of zanamavir with haem agglutinin neuraminidase of human para influenza virus type 3 Indumathi CP, Bupesh G, Vasanth S, Senthilkumar V, Anandh AV, Pandian K	Bioinformation	2019
Haemagglutinin-neuraminidase from HPIV3 mediates human NK regulation of T cell proliferation via NKp44 and NKp46 S McQuaid, S Loughran, P Power, P Maguire, D Walls, MG Cusi, C Orvell, P Johnson	Journal of General Virology	2018
Structural Insights into Human Parainfluenza Virus 3 Hemagglutinin–Neuraminidase Using Unsaturated 3- N -Substituted Sialic Acids as Probes M Pascolutti, L Dirr, P Guillon, AV Bergh, T Ve, RJ Thomson, M von Itzstein	ACS chemical biology	2018
Human Parainfluenza Virus Type 3 Matrix Protein Reduces Viral RNA Synthesis of HPIV3 by Regulating Inclusion Body Formation S Zhang, Q Cheng, C Luo, Y Qin, M Chen	Viruses	2018
Detailed genetic analyses of the HN gene in human respirovirus 3 detected in children with acute respiratory illness in the Iwate Prefecture, Japan M Takahashi, K Nagasawa, K Saito, S Maisawa, K Fujita, K Murakami, M Kuroda, A Ryo, H Kimura	Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases	2018
The Sialic Acid Binding Activity of Human Parainfluenza Virus 3 and Mumps Virus Glycoproteins Enhances the Adherence of Group B Streptococci to HEp-2 Cells J Tong, Y Fu, F Meng, N Krüger, P Valentin-Weigand, G Herrler	Frontiers in Cellular and Infection Microbiology	2018
An alanine residue in human parainfluenza virus type 3 phosphoprotein is critical for restricting excessive N 0 -P interaction and maintaining N solubility S Zhang, Q Cheng, C Luo, L Yin, Y Qin, M Chen	Virology	2018
UK circulating strains of human parainfluenza 3: an amplicon based next generation sequencing method and phylogenetic analysis A Smielewska, E Emmott, K Ranellou, A Popay, I Goodfellow, H Jalal	Wellcome Open Research	2018
A chimeric glycoprotein formulated with a combination adjuvant induces protective immunity against both human respiratory syncytial virus and parainfluenza virus type 3 R Garg, R Brownlie, L Latimer, V Gerdts, A Potter, S van Drunen Littel-van den Hurk	Antiviral Research	2018
UK circulating strains of human parainfluenza 3: an amplicon based next generation sequencing method and phylogenetic analysis Smielewska A, Emmott E, Ranellou K, Popay A, Goodfellow I, Jalal H	Wellcome Open Research	2018
The impact of the butterfly effect on human parainfluenza virus haemagglutinin-neuraminidase inhibitor design L Dirr, IM El-Deeb, LM Chavas, P Guillon, M Itzstein	Scientific Reports	2017
Characterizing the Cellular Immune Response to Parainfluenza Virus 3 PI Aguayo-Hiraldo, RJ Arasaratnam, I Tzannou, M Kuvalekar, P Lulla, S Naik, CA Martinez, PA Piedra, JF Vera, AM Leen	The Journal of Infectious Diseases	2017
Vaccination with a human parainfluenza virus type 3 chimeric FHN glycoprotein formulated with a combination adjuvant induces protective immunity R Garg, R Brownlie, L Latimer, V Gerdts, A Potter, SD Hurk	Vaccine	2017
Exploring inhibitor structural features required to engage the 216-loop of human parainfluenza virus type-3 hemagglutinin-neuraminidase IM El-Deeb, P Guillon, L Dirr, M von Itzstein	MedChemComm	2017
Inflammasome antagonism by human parainfluenza virus type 3 C protein NK Shil, SM Pokharel, AK Banerjee, M Hoffman, S Bose	Journal of virology	2017
A dual drug regimen synergistically blocks human parainfluenza virus infection B Bailly, L Dirr, IM El-Deeb, R Altmeyer, P Guillon, M Itzstein	Scientific Reports	2016
A study of genetic variability of human parainfluenza virus type 1 in Croatia, 2011–2014 D Forčić, G Mlinarić-Galinović, S Ljubin-Sternak, A Slovic, T Košutić-Gulija	Journal of Medical Microbiology	2016
Features of Circulating Parainfluenza Virus Required for Growth in Human Airway LM Palermo, M Uppal, L Skrabanek, P Zumbo, S Germer, NC Toussaint, BK Rima, D Huey, S Niewiesk, M Porotto, A Moscona	mBio	2016
Human parainfluenza virus-3 can be targeted by rapidly ex vivo expanded T lymphocytes LP McLaughlin, H Lang, E Williams, KE Wright, A Powell, CR Cruz, AM Colberg-Poley, C Barese, PJ Hanley, CM Bollard, MD Keller	Cytotherapy	2016
Parainfluenza Virus Infection Branche AR, Falsey AR	Seminars in respiratory and critical care medicine	2016
Virus Infection of Airway Epithelial Cells Alexander-Brett J, Holtzman MJ	Mucosal Immunology	2015
The Catalytic Mechanism of Human Parainfluenza Virus Type 3 Haemagglutinin-Neuraminidase Revealed L Dirr, IM El-Deeb, P Guillon, CJ Carroux, LM Chavas, M von Itzstein	Angewandte Chemie (International ed. in English)	2015
The Catalytic Mechanism of Human Parainfluenza Virus Type 3 Haemagglutinin-Neuraminidase Revealed L Dirr, IM El-Deeb, P Guillon, CJ Carroux, LM Chavas, M von Itzstein	Angewandte Chemie	2015
Isolation & molecular characterization of human parainfluenza virus in Chennai, India CP Indumathi, P Gunanasekaran, K Kaveri, K Arunagiri, S Mohana, AK Sheriff, BV SureshBabu, P Padmapriya, R Senthilraja, G Fathima	The Indian journal of medical research	2015
Human Respiratory Viral Infections TM Mak, R Lin, YJ Tan	Human Respiratory Viral Infections	2014
DAS181 treatment of hematopoietic stem cell transplant patients with parainfluenza virus lung disease requiring mechanical ventilation S Chalkias, MR Mackenzie, C Gay, C Dooley, FM Marty, RB Moss, T Li, RL Routh, SR Walsh, CS Tan	Transplant Infectious Disease	2014
Parainfluenza virus type 3 Ab in allogeneic hematopoietic cell transplant recipients: factors influencing post-transplant Ab titers and associated outcomes S Seo, H Xie, RA Karron, B Thumar, JA Englund, WM Leisenring, T Stevens-Ayers, M Boeckh, AP Campbell	Bone Marrow Transplantation	2014
Structure-guided discovery of potent and dual-acting human parainfluenza virus haemagglutinin–neuraminidase inhibitors P Guillon, L Dirr, IM El-Deeb, M Winger, B Bailly, T Haselhorst, JC Dyason, M Itzstein	Nature Communications	2014
Molecular evolution of the haemagglutinin-neuraminidase gene in human parainfluenza virus type 3 isolates from children with acute respiratory illness in Yamagata prefecture, Japan K Mizuta, H Tsukagoshi, T Ikeda, Y Aoki, C Abiko, T Itagaki, M Nagano, M Noda, H Kimura	Journal of Medical Microbiology	2014
Genetic analysis of human parainfluenza viruses circulating in Korea, 2006: Genetic Analysis of Human Parainfluenza Viruses in Korea KS Park, MH Yang, CK Lee, KJ Song	Journal of Medical Virology	2014
Circulating Clinical Strains of Human Parainfluenza Virus Reveal Viral Entry Requirements for In Vivo Infection SG Palmer, I DeVito, SG Jenkins, S Niewiesk, M Porotto, A Moscona	Journal of virology	2014
Viral Infections of Humans RA Kaslow, LR Stanberry, JW Duc		2014
a-Position-Mutated and G4-Mutated Hemagglutinin-Neuraminidase Proteins of Newcastle Disease Virus Impair Fusion and Hemagglutinin-Neuraminidase-Fusion Interaction by Different Mechanisms F Chu, H Wen, W Zhang, B Lin, Y Zhang, C Sun, G Ren, Y Song, Z Wang	Intervirology	2013
Role of N-linked glycosylation of the human parainfluenza virus type 3 hemagglutinin-neuraminidase protein F Chu, H Wen, G Hou, B Lin, W Zhang, Y Song, G Ren, C Sun, Z Li, Z Wang	Virus Research	2013
The use of sialidase therapy for respiratory viral infections JM Nicholls, RB Moss, SM Haslam	Antiviral Research	2013
Characterization of a key residue for hyperfusogenic phenotype in human parainfluenza virus type 2 (hPIV-2) fusion glycoprotein JC Bayon, O Terrier, G Cartet, B Lina, M Rosa-Calatrava	Virus Genes	2013
Vaccines RW Sutter, OM Kew, SL Cochi, RB Aylward	Human vaccines	2013
Development of oligomannose-coated liposome-based nasal vaccine against human parainfluenza virus type 3 K Senchi, S Matsunaga, H Hasegawa, H Kimura, A Ryo	Frontiers in microbiology	2013
Measles virus fusion machinery activated by sialic acid binding globular domain A Talekar, A Moscona, M Porotto	Journal of virology	2013
Identification of a region in the stalk domain of the nipah virus receptor binding protein that is critical for fusion activation A Talekar, I DeVito, Z Salah, SG Palmer, A Chattopadhyay, JK Rose, R Xu, IA Wilson, A Moscona, M Porotto	Journal of virology	2013
Interaction between the Hemagglutinin-Neuraminidase and Fusion Glycoproteins of Human Parainfluenza Virus Type III Regulates Viral Growth In Vivo R Xu, SG Palmer, M Porotto, LM Palermo, S Niewiesk, IA Wilson, A Moscona	mBio	2013
Characterization of a key residue for hyperfusogenic phenotype in human parainfluenza virus type 2 (hPIV-2) fusion glycoprotein. Le Bayon JC, Terrier O, Cartet G, Lina B, Rosa-Calatrava M	Virus Genes	2013
Current management of parainfluenza pneumonitis in immunocompromised patients: a review AR Falsey	Infection and drug resistance	2012
Adaptation of Human Parainfluenza Virus to Airway Epithelium Reveals Fusion Properties Required for Growth in Host Tissue SG Palmer, M Porotto, LM Palermo, LF Cunha, O Greengard, A Moscona	mBio	2012
A General Strategy to Endow Natural Fusion-protein-Derived Peptides with Potent Antiviral Activity A Pessi, A Langella, E Capitò, S Ghezzi, E Vicenzi, G Poli, T Ketas, C Mathieu, R Cortese, B Horvat, A Moscona, M Porotto	PloS one	2012
Molecular characterization and phylogenetic analysis of human parainfluenza virus type 3 isolated from Saudi Arabia FN Almajhdi, MS Alshaman, HM Amer	Journal of Medical Virology	2012
The second receptor binding site of the globular head of the Newcastle disease virus hemagglutinin-neuraminidase activates the stalk of multiple paramyxovirus receptor binding proteins to trigger fusion M Porotto, Z Salah, I DeVito, A Talekar, SG Palmer, R Xu, IA Wilson, A Moscona	Journal of virology	2012
Regulation of paramyxovirus fusion activation: the hemagglutinin-neuraminidase protein stabilizes the fusion protein in a pretriggered state M Porotto, ZW Salah, L Gui, I DeVito, EM Jurgens, H Lu, CC Yokoyama, LM Palermo, KK Lee, A Moscona	Journal of virology	2012
A General Strategy to Endow Natural Fusion-protein-Derived Peptides with Potent Antiviral Activity A Pessi, A Langella, E Capitò, S Ghezzi, E Vicenzi, G Poli, T Ketas, C Mathieu, R Cortese, B Horvat, A Moscona, M Porotto, C Liang	PloS one	2012
Illumination of Parainfluenza Virus Infection and Transmission in Living Animals Reveals a Tissue-Specific Dichotomy CW Burke, JN Mason, SL Surman, BG Jones, E Dalloneau, JL Hurwitz, CJ Russell, RA Fouchier	PLoS pathogens	2011
Cough reflex sensitivity is increased in guinea pigs with parainfluenza virus infection XM Ye, NS Zhong, CL Liu, RC Chen	Experimental Lung Research	2011
Detailed genetic analysis of hemagglutinin-neuraminidase glycoprotein gene in human parainfluenza virus type 1 isolates from patients with acute respiratory infection between 2002 and 2009 in Yamagata prefecture, Japan K Mizuta, M Saitoh, M Kobayashi, H Tsukagoshi, Y Aoki, T Ikeda, C Abiko, N Katsushima, T Itagaki, M Noda, K Kozawa, T Ahiko, H Kimura	Virology Journal	2011
Tropical Infectious Diseases: Principles, Pathogens and Practice TB Nutman, JW Kazura	Tropical Infectious Diseases: Principles, Pathogens and Practice	2011
Mechanism of fusion triggering by human parainfluenza virus type III: communication between viral glycoproteins during entry M Porotto, SG Palmer, LM Palermo, A Moscona	The Journal of biological chemistry	2011
Mechanism of Fusion Triggering by Human Parainfluenza Virus Type III M Porotto, SG Palmer, LM Palermo, A Moscona	The Journal of biological chemistry	2011
Premature activation of the paramyxovirus fusion protein before target cell attachment with corruption of the viral fusion machinery SF Farzan, LM Palermo, CC Yokoyama, G Orefice, M Fornabaio, A Sarkar, GE Kellogg, O Greengard, M Porotto, A Moscona	The Journal of biological chemistry	2011
Spring-Loaded Model Revisited: Paramyxovirus Fusion Requires Engagement of a Receptor Binding Protein beyond Initial Triggering of the Fusion Protein M Porotto, I DeVito, SG Palmer, EM Jurgens, JL Yee, CC Yokoyama, A Pessi, A Moscona	Journal of virology	2011
Respiratory Viral Infections Proença-Módena JL, Acrani GO, Snider CB, Arruda E	Tropical Infectious Diseases: Principles, Pathogens and Practice	2011
A recombinant sialidase fusion protein effectively inhibits human parainfluenza viral infection in vitro and in vivo A Moscona, M Porotto, S Palmer, C Tai, L Aschenbrenner, G Triana-Baltzer, QX Li, D Wurtman, S Niewiesk, F Fang	The Journal of Infectious Diseases	2010
A single amino acid mutation at position 170 of human parainfluenza virus type 1 fusion glycoprotein induces obvious syncytium formation and caspase-3-dependent cell death M Takaguchi, T Takahashi, C Hosokawa, H Ueyama, K Fukushima, T Hayakawa, K Itoh, K Ikeda, T Suzuki	Journal of Biochemistry	2010
Antiviral effect of strictinin on influenza virus replication RK Saha, T Takahashi, Y Kurebayashi, K Fukushima, A Minami, N Kinbara, M Ichitani, YM Sagesaka, T Suzuki	Antiviral Research	2010
Residues in the Heptad Repeat A Region of the Fusion Protein Modulate the Virulence of Sendai Virus in Mice LE Luque, OA Bridges, JN Mason, KL Boyd, A Portner, CJ Russell	Journal of virology	2010
Integrative Medicine for Children M Loo	Integrative Medicine for Children	2009
Integrin alphavbeta1 promotes infection by human metapneumovirus G Cseke, MS Maginnis, RG Cox, SJ Tollefson, AB Podsiad, DW Wright, TS Dermody, JV Williams	Proceedings of the National Academy of Sciences	2009
Glycoprotein interactions in paramyxovirus fusion RM Iorio, VR Melanson, PJ Mahon	Future Virology	2009
Neuraminidase-deficient Sendai virus HN mutants provide protection from homologous superinfection CA Baumann, WJ Neubert	Archives of Virology	2009
Human parainfluenza virus type 2 (HPIV2) induced host ADAM8 expression in human salivary adenocarcinoma cell line (HSY) during cell fusion GF Ma, S Miettinen, P Porola, K Hedman, J Salo, YT Konttinen	BMC Microbiology	2009
Aurintricarboxylic acid inhibits influenza virus neuraminidase HC Hung, CP Tseng, JM Yang, YW Ju, SN Tseng, YF Chen, YS Chao, HP Hsieh, SR Shih, JT Hsu	Antiviral Research	2009
Human Parainfluenza Virus Infection of the Airway Epithelium: Viral Hemagglutinin-Neuraminidase Regulates Fusion Protein Activation and Modulates Infectivity LM Palermo, M Porotto, CC Yokoyama, SG Palmer, BA Mungall, O Greengard, S Niewiesk, A Moscona	Journal of virology	2009
Upper Respiratory Tract Infection Loo M	Integrative Medicine for Children	2009
Inhibition of human parainfluenza virus type 3 infection by novel small molecules H Mao, CS Thakur, S Chattopadhyay, RH Silverman, A Gudkov, AK Banerjee	Antiviral Research	2008
Molecular strategies to inhibit the replication of RNA viruses P Leyssen, ED Clercq, J Neyts	Antiviral Research	2008
Characterization of naturally occurring parainfluenza virus type 2 (hPIV-2) variants O Terrier, G Cartet, O Ferraris, F Morfin, D Thouvenot, SS Hong, B Lina	Journal of Clinical Virology	2008
A daring treatment and a successful outcome: The need for targeted therapies for pediatric respiratory viruses P DeLaMora, A Moscona	Pediatric Transplantation	2007
Detection of Parainfluenza Virus 3 in Turbinate Epithelial Cells of Postviral Olfactory Dysfunction Patients JH Wang, HJ Kwon, YJ Jang	The Laryngoscope	2007
Molecular Determinants of Antiviral Potency of Paramyxovirus Entry Inhibitors M Porotto, P Carta, Y Deng, GE Kellogg, M Whitt, M Lu, BA Mungall, A Moscona	Journal of virology	2007
A Second Receptor Binding Site on Human Parainfluenza Virus Type 3 Hemagglutinin-Neuraminidase Contributes to Activation of the FusionMechanism M Porotto, M Fornabaio, GE Kellogg, A Moscona	Journal of virology	2007
Fusion Promotion by a Paramyxovirus Hemagglutinin-Neuraminidase Protein: pH Modulation of Receptor Avidity of Binding Sites I and II LM Palermo, M Porotto, O Greengard, A Moscona	Journal of virology	2007
The Cell Biology of Acute Childhood Respiratory Disease: Therapeutic Implications GM Loughlin, A Moscona	Pediatric Clinics of North America	2006
Inhibition of hendra virus fusion M Porotto, L Doctor, P Carta, M Fornabaio, O Greengard, GE Kellogg, A Moscona	Journal of virology	2006
Paramyxovirus receptor-binding molecules: engagement of one site on the hemagglutinin-neuraminidase protein modulates activity at the second site M Porotto, M Fornabaio, O Greengard, MT Murrell, GE Kellogg, A Moscona	Journal of virology	2006
Mucosal Immunology WR Brown	Mucosal Immunology	2005

Advertisement